Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  IQVIA Holdings Inc.    IQV

IQVIA HOLDINGS INC.

(IQV)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
11/20/2020 11/23/2020 11/24/2020 11/25/2020 11/27/2020 Date
169.77(c) 170.56(c) 172(c) 169.87(c) 168.81(c) Last
606 018 682 754 742 794 817 074 591 734 Volume
+0.13% +0.47% +0.84% -1.24% -0.62% Change
More quotes
Financials (USD)
Sales 2020 11 206 M - -
Net income 2020 332 M - -
Net Debt 2020 10 414 M - -
P/E ratio 2020 98,8x
Yield 2020 -
Sales 2021 12 520 M - -
Net income 2021 695 M - -
Net Debt 2021 10 287 M - -
P/E ratio 2021 46,3x
Yield 2021 -
Capitalization 32 365 M 32 365 M -
EV / Sales 2020 3,82x
EV / Sales 2021 3,41x
Nbr of Employees 68 000
Free-Float 74,5%
More Financials
Company
IQVIA Holdings Inc., formerly Quintiles IMS Holdings, Inc., provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions,... 
More about the company
Notations Surperformance© of IQVIA Holdings Inc.
Trading Rating : Investor Rating :
More Ratings
All news about IQVIA HOLDINGS INC.
11/19IQVIA : Q3 2020 Earnings Call - Presentation
PU
11/02IQVIA : 's Orchestrated Customer Engagement Platform Selected by Zentiva to Acce..
BU
10/22IQVIA : Management's Discussion and Analysis of Financial Condition and Results ..
AQ
10/20IQVIA : 3Q Earnings Snapshot
AQ
10/20IQVIA HOLDINGS INC. : Results of Operations and Financial Condition, Financial S..
AQ
10/20IQVIA : Reports Third-Quarter 2020 Results, Raises Full-Year 2020 Guidance and P..
BU
10/15IQVIA HOLDINGS INC. : quaterly earnings release
10/12IQVIA : Joins FDA to Advance COVID-19 Understanding at Community Level through C..
BU
10/07IQVIA : to Announce Third-Quarter Results on October 20, 2020
BU
10/06IQVIA INSTITUTE FOR HUMAN DATA SCIEN : Biosimilars Reach Inflection Point &ndash..
BU
10/05IQVIA : and Medvarsity Collaborate to Provide Flexible Medical Training Solution..
PU
09/14IQVIA : 's eCOA Solution Receives 2020 Fierce Innovation Award
BU
09/01FACTBOX : AstraZeneca's potential coronavirus vaccine
RE
08/31IQVIA : 's RIM Smart Honored as Gold Stevie® Award Winner in 2020 American Busin..
BU
08/06FACTBOX : AstraZeneca's potential coronavirus vaccine
RE
More news
News in other languages on IQVIA HOLDINGS INC.
10/15Corona-Krise wirbelt den Apothekenmarkt weiter durcheinander
10/15ANALYSTEN :  Versandapotheken haben Marktanteil in der Krise gesteigert
10/15IQVIA HOLDINGS INC. : publication des résultats trimestriels
10/15IQVIA HOLDINGS INC. : Veröffentlichung des Quartalsergebnisses
08/17AUSBLICK ALCON : Q2-Umsatz von 1,2 Milliarden US-Dollar erwartet
More news
Chart IQVIA HOLDINGS INC.
Duration : Period :
IQVIA Holdings Inc. Technical Analysis Chart | IQV | US46266C1053 | MarketScreener
Technical analysis trends IQVIA HOLDINGS INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 21
Average target price 196,26 $
Last Close Price 168,81 $
Spread / Highest target 34,5%
Spread / Average Target 16,3%
Spread / Lowest Target -7,00%
EPS Revisions
Managers
NameTitle
Ari Bousbib Chairman, President & Chief Executive Officer
James Grant Berkshire Senior Vice President-Business Operations
Ronald Earl Bruehlman Chief Financial Officer & Executive Vice President
Karl Guenault Chief Information Officer & Senior Vice President
John M. Leonard Lead Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
IQVIA HOLDINGS INC.9.26%32 365
HANGZHOU TIGERMED CONSULTING CO.,LTD79.46%15 070
PRA HEALTH SCIENCES, INC.-0.14%7 120
SYNEOS HEALTH, INC.12.08%6 932
NOVAVAX, INC.2,477.89%6 427
FIBROGEN, INC.-6.34%3 656